Heidelberg Pharma AG

Heidelberg Pharma AGverified

HPHA.DE

Price:

$2.42

Market Cap:

$113.22M

Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. Its lead product candidate is HDP-101, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It is developing HDP-102 for the treatment of non-Hodgkin lymphoma; HDP-103, an ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for tumors; and HDP-XX for the treatment of solid/hematological tumors. The company is also developing MGTA-ATACs for HSCs, conditioning programs to treat blood cancers/genetic diseases; TAK-ATACs for oncology...[Read more]

Industry

Biotechnology

IPO Date

2006-11-13

Stock Exchange

XETRA

Ticker

HPHA.DE

The PE Ratio as of December 2025 (TTM) for Heidelberg Pharma AG (HPHA.DE) is -4.32

According to Heidelberg Pharma AG’s latest financial reports and current stock price. The company's current PE Ratio is -4.32. This represents a change of -20.91% compared to the average of -5.46 of the last 4 quarters.

Heidelberg Pharma AG (HPHA.DE) Historical PE Ratio (quarterly & annually)

How has HPHA.DE PE Ratio performed in the past?

The mean historical PE Ratio of Heidelberg Pharma AG over the last ten years is -6.47. The current -4.32 PE Ratio has changed 6.57% with respect to the historical average. Over the past ten years (40 quarters), HPHA.DE's PE Ratio was at its highest in in the August 2023 quarter at 356.10. The PE Ratio was at its lowest in in the May 2022 quarter at -30.64.

Quarterly (TTM)
Annual

Average

-6.47

Median

-6.32

Minimum

-10.81

Maximum

-2.33

Heidelberg Pharma AG (HPHA.DE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Heidelberg Pharma AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 249.13%

Maximum Annual PE Ratio = -2.33

Minimum Annual Increase = -56.05%

Minimum Annual PE Ratio = -10.81

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.77-8.70%
2023-6.32-41.53%
2022-10.8171.00%
2021-6.32-25.28%
2020-8.4637.73%
2019-6.14-10.50%
2018-6.8691.91%
2017-3.58-56.05%
2016-8.14249.13%
2015-2.33-18.88%

Heidelberg Pharma AG (HPHA.DE) Average PE Ratio

How has HPHA.DE PE Ratio performed in the past?

The current PE Ratio of Heidelberg Pharma AG (HPHA.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-7.63

5-year avg

-7.54

10-year avg

-6.47

Heidelberg Pharma AG (HPHA.DE) PE Ratio vs. Peers

How is HPHA.DE’s PE Ratio compared to its peers?

Heidelberg Pharma AG’s PE Ratio is greater than 4basebio PLC (-6.99), greater than Zura Bio Limited (-6.02), greater than BRAIN Biotech AG (-4.91), less than Healwell AI Inc (-3.39), less than Mediclin AG (4.91), greater than FamiCord AG (-10.25), less than LIMES Schlosskliniken AG (22.45), less than MPH Health Care AG (-0.88), less than Apontis Pharma AG (140.00), less than H100 Group AB N (-1.94),

Build a custom stock screener for Heidelberg Pharma AG (HPHA.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heidelberg Pharma AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Heidelberg Pharma AG (HPHA.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Heidelberg Pharma AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Heidelberg Pharma AG's PE Ratio?

How is the PE Ratio calculated for Heidelberg Pharma AG (HPHA.DE)?

What is the highest PE Ratio for Heidelberg Pharma AG (HPHA.DE)?

What is the 3-year average PE Ratio for Heidelberg Pharma AG (HPHA.DE)?

What is the 5-year average PE Ratio for Heidelberg Pharma AG (HPHA.DE)?

How does the current PE Ratio for Heidelberg Pharma AG (HPHA.DE) compare to its historical average?